Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Nabi files BLA for use of Nabi-HB in liver transplant patients

Nov. 29, 2002

Positive opinion issued in E.U. for Hepsera

Nov. 26, 2002

Alicaforsen enters new phase II trial in active ulcerative colitis

Nov. 25, 2002

Lotronex available under restricted use for women with diarrhea-predominant IBS

Nov. 25, 2002

BioPartners to use Durect technology to produce sustained-release interferon alfa

Nov. 21, 2002

Aciphex combination treatment approved for seven-day eradication of H. pylori

Nov. 21, 2002

FDA advisory committee recommends approval of Pegasys in combination with Copegus

Nov. 18, 2002

New beta3-adrenoceptor agonists covered by Asahi patent

Nov. 18, 2002

Albuferon in chronic hepatitis C

Nov. 15, 2002

Amantadine in combination therapies for hepatitis C

Nov. 15, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
In the clinic for June 12, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Anixa, Beone, Bioinvent, Blossomhill, C4, Cellectis, Climb, Elixiron,...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...